Peptides that regulate feeding behavior via the brain may also regulate energy storage and expenditure in the adipose tissue, a system collectively known as the "brain-fat axis". Neuropeptide Y (NPY) is orexigenic and promotes adipogenesis in both birds and mammals, although mechanisms in adipose tissue are unclear. The first objective was thus to evaluate effects of NPY on chick preadipocyte proliferation and differentiation. Preadipocytes were treated with NPY and gene expression and cellular proliferation were evaluated. Cells were also treated with NPY during differentiation and harvested during the later stages. With increased gene expression of proliferation markers in preadipocytes, and during differentiation increased expression of adipogenesis-associated factors, increased lipid accumulation, and increased activity of an adipogenic enzyme, glycerol-3-phosphate dehydrogenase, results suggest that NPY may enhance preadipocyte activity and adipogenesis and promotes lipid accumulation throughout chicken adipocyte differentiation. Another appetite-regulatory peptide, alpha-melanocyte stimulating hormone (α-MSH), is anorexigenic and mediates lipolysis in adipose tissue, but effects on fat in avians are unreported. The second objective was thus to determine the effects of exogenous α-MSH on adipose tissue physiology in broiler chicks. Chicks were intraperitoneally injected with α-MSH and adipose tissue and plasma collected. Cells isolated from abdominal fat of a different set of chicks were treated with α-MSH. Results suggest that α-MSH increases lipolysis and reduces adipogenesis in chick adipose tissue. Collectively, results of this research provide insights on how appetite-regulatory peptides like NPY and α-MSH affect adipose tissue physiology, thereby playing important roles in regulating whole-body energy balance. / Master of Science / Peptides that contribute to feeding behavior via the brain may also affect the way energy is stored and released in the adipose tissue. Neuropeptide Y (NPY) is a neurotransmitter that induces hunger, and promotes the growth of adipose tissue in both birds and mammals, although mechanisms in adipose tissue are unclear. The first objective was thus to evaluate effects of NPY on chick preadipocyte activity and the process by which preadipocyte cells differentiate into fully matures adipocytes, a process termed adipogenesis. Preadipocytes were treated with NPY and gene expression and cellular division were evaluated. Cells were also treated with NPY during differentiation and harvested during the later stages. With increased activity in preadipocytes, and during differentiation greater activity leading to increased fat accumulation, results suggest that NPY may enhance preadipocyte activity and adipogenesis and promotes fat accumulation throughout chicken adipocyte differentiation. Another appetite-regulatory peptide, alpha-melanocyte stimulating hormone (α-MSH), inhibits hunger and breaks down adipose tissue, but effects on fat in avians are unreported. The second objective was thus to determine the effects of α-MSH on adipose tissue physiology in chicks. Chicks were injected with α-MSH and cells isolated from abdominal fat of a different set of chicks were treated with α-MSH. Results suggest that α-MSH breaks down fat and reduces adipogenesis in chick adipose tissue. Collectively, results of this research provide insights on how NPY and α-MSH affect adipose tissue physiology, thereby playing important roles in regulating whole-body energy balance.

<p>Neuropeptide Y (NPY) is an abundant neurotransmitter in the nervous system and forms a family of evolutionarily related peptides together with peptide YY (PYY), pancreatic polypeptide (PP) and polypeptide Y (PY). These peptides are ligands to a family of receptors that mediate a wide range of physiological effects including stimulation of appetite. This work describes the molecular cloning of four novel NPY receptors.</p><p>In rat a receptor called PP1, later renamed Y₄, was cloned and characterized. It displays the highest amino acid sequence identity to the Y₁ receptor. Rat Y₄ differs extensively from human Y₄, cloned subsequently, in both pharmacological properties, tissue distribution, and amino acid sequence with only 75% identity. Rat and human Y₄are the most diverged orthologues in the NPY receptor family.</p><p>In guinea pig, the y₆ receptor gene was found to be a pseudogene with several frameshift mutations. The gene is a pseudogene in human and pig too, but seems to give rise to a functional receptor in mouse and rabbit. This unusual evolutionary situa- tion may be due to inactivation of the gene in a mammalian ancestor and then restoration of expression in mouse and rabbit, but perhaps more likely due to independent inactivations in guinea pig, human and pig.</p><p>In zebrafish, two new intronless receptor genes were cloned. Sequence comparisons suggest that both receptors are distinct from the mammalian receptors Y₁, Y₄ and y₆, hence they were named Ya and Yb. Chromosomal localization provides further support that Ya and Yb may be distinct subtypes. </p><p>The discoveries of the rat Y₄ and zebrafish Ya and Yb receptors were unexpected and show that the NPY receptor family is larger than previously thought.</p>

Neuropeptide Y (NPY) is an abundant neurotransmitter in the nervous system and forms a family of evolutionarily related peptides together with peptide YY (PYY), pancreatic polypeptide (PP) and polypeptide Y (PY). These peptides are ligands to a family of receptors that mediate a wide range of physiological effects including stimulation of appetite. This work describes the molecular cloning of four novel NPY receptors. In rat a receptor called PP1, later renamed Y4, was cloned and characterized. It displays the highest amino acid sequence identity to the Y1 receptor. Rat Y4 differs extensively from human Y4, cloned subsequently, in both pharmacological properties, tissue distribution, and amino acid sequence with only 75% identity. Rat and human Y4 are the most diverged orthologues in the NPY receptor family. In guinea pig, the y6 receptor gene was found to be a pseudogene with several frameshift mutations. The gene is a pseudogene in human and pig too, but seems to give rise to a functional receptor in mouse and rabbit. This unusual evolutionary situa- tion may be due to inactivation of the gene in a mammalian ancestor and then restoration of expression in mouse and rabbit, but perhaps more likely due to independent inactivations in guinea pig, human and pig. In zebrafish, two new intronless receptor genes were cloned. Sequence comparisons suggest that both receptors are distinct from the mammalian receptors Y1, Y4 and y6, hence they were named Ya and Yb. Chromosomal localization provides further support that Ya and Yb may be distinct subtypes. The discoveries of the rat Y4 and zebrafish Ya and Yb receptors were unexpected and show that the NPY receptor family is larger than previously thought.

Für alle Tiere ist die Nahrungsaufnahme ein überlebenswichtiger Vorgang. Das konsumatorische Verhalten ist Teilaspekt eines homöostatischen Prozesses. Ausgelöst wird konsumatorisches und appetitives Verhalten durch interne, motivationale Zustände. Die internen Zustände „gesättigt“ und „ungesättigt“ werden bei vielen Tierarten durch ein Wechselspiel zwischen orexigen- und anorexigen-wirkenden Neuropeptiden vermittelt. Um die zentralnervöse Steuerung von Appetit und Sättigung genauer zu klären, wurde in dieser Studie die schwarzbäuchige Taufliege Drosophila melanogaster als Modellorganismus genutzt. Dabei konnte gezeigt werden, dass durch eine artifizielle, thermogenetisch induzierte Aktivierung von Neuronen, welche das Neuropeptid SIFamid exprimieren, das Verhalten der Insekten verändert wird. Die Tiere zeigen vermehrte Nahrungsaufnahme und sind motivierter, auf appetitive gustatorische und olfaktorische Reize zu reagieren. Des Weiteren wurden Hinweise gesammelt, dass das Neuropeptid SIFamid keinen inhibitorischen Einfluss auf das Balzverhalten der Taufliegen ausübt. Mit immunhistochemischen Färbungen konnte gezeigt werden, dass die Dendriten der SIFamidergen Neurone in unmittelbarer Nähe zu den Axonendigungen von Neuronen, die orexigen- oder anorexigen-wirkende Neuropeptide produzieren, liegen. Dieser Befund lässt auf ein mögliches Zusammenspiel zwischen den diversen peptidergen Neuronen schließen. Mit Hilfe der split-GFP-Technik konnte das peptiderge Netzwerk der SIFamidergen Neurone detaillierter untersucht werden. Es wurde gefunden, dass die SIFamidergen Neurone in enger räumlicher Nachbarschaft zu Neuronen, die in die Nahrungsaufnahme sowie die nervöse Steuerung des Metabolismus involviert sind, stehen. In Kombination mit einem zweiten, unabhängigen Expressionssystem konnten die SIFamidergen Neurone thermogenetisch depolarisiert werden und die neuronale Antwort der olfaktorischen Rezeptorneurone auf Duftstimuli in den Antennalloben mit Hilfe von in-vivo Calcium Imaging untersucht werden. Es konnte dadurch gezeigt werden, dass die neuronale Aktivität in den Duftsinneszellen erhöht ist. Aufgrund vorliegender Daten aus Anatomie, Verhaltensexperimenten und in-vivo Calcium Imaging lässt sich schlussfolgern, dass SIFamid ein bis dato unbekannter „Mitspieler“ bei der Steuerung der Nahrungsaufnahme ist und modulierend auf sensorische neuronale Schaltkreise sowie insgesamt appetitfördernd auf die Taufliege wirkt.

Dans le but d’étudier le rôle fonctionnel des neuropeptides chez la drosophile, nous avons essayé d’utiliser le récepteur µ aux opioïdes (MOR) afin d’inhiber temporairement la libération de neuropeptides. Cependant, quand nous l’avons exprimé dans les cellules endocrines produisant l’hormone adipokinétique (AKH), le récepteur MOR a présenté une activité constitutive empêchant tout contrôle dans le temps. Nous proposons d’utiliser les récepteurs RASSL (Receptors Activated Solely by Synthetic Ligands) développés chez les vertébrés. Ces récepteurs, activés uniquement par des ligands synthétiques, ont été modifiés afin qu’ils soient dénués d’activité constitutive. Afin de tester rapidement l’efficacité d’un récepteur RASSL inhibiteur chez la drosophile, nous avons cherché une alternative à la mesure des taux de tréhalose et de glycogène (démontrant la libération d’AKH) qui en plus d’être laborieuse produit des résultats variables. L’hormone GPA2/GPB5, récemment découverte, est particulièrement intéressante, en effet, elle semble avoir un rôle antidiurétique. Nous avons généré des lignées transgéniques exprimant la protéine Gal4 dans les cellules GAP2/GPB5 et nous avons montré que l’ablation génétique de ces cellules compromet la survie suggérant qu’elles pourraient représenter un bon système pour tester l’efficacité du RASSL inhibiteur. Ensuite nous nous sommes intéressés au contrôle de la libération du neuropeptide AKH qui a un rôle fonctionnel homologue à celui du glucagon des vertébrés. Malgré quelques résultats encourageants, nous n’avons pas pu confirmer le rôle inhibiteur de l’AstA sur la libération de l’AKH. Enfin nous nous sommes intéressés au réseau qui contrôle le comportement de cour. Nous avons généré des lignées transgéniques exprimant la protéine Gal4 sous la dépendance du promoteur potentiel du récepteur du neuropeptide SIFamide (SIFR) et nous avons démontré que ce neuropeptide contrôle le comportement de cour via son récepteur SIFR en agissant, du moins en partie, sur les neurones fruitless. / In order to study the functional roles of neuropeptides in Drosophila, I attempted to use the µ opioïd receptor (MOR) to temporarily inhibit liberation of neuropeptides. However, when expressed in the AKH (adipokinetic hormone) endocrine cells of Drosophila, MOR turned out to be constitutively active, making it impossible to use it as envisioned. Others have encountered and subsequently solved similar problems for the so-called RASSL (Receptors Activated Solely by Synthetic Ligands) in vertebrates. As the bioassay for testing release of AKH is cumbersome, time-consuming and variable, I searched for an alternative neuroendocrine system to test the efficiency of an inhibitory RASSL in Drosophila. The recently discovered GPA2/GPB5 seemed particularly attractive, as it is likely an antidiuretic hormone. Transgenic flies expressing Gal4 in the GPA2/GPB5 were produced and genetic ablation of these cells severely compromised survival, suggesting that this might indeed be good model system. Attempts so demonstrate a physiological role of allatostatin A in the release of AKH yielded inconclusive results. In order to study the role of the neuropeptide SIFamide, which modulates sexual behavior in Drosophila, I generated transgenic flies expressing Gal4 under dependence of potential promoter of this neuropeptide receptor (SIFR) and showed that SIFamide controls courtship at least in part by acting directly on fruitless neurons.

L’ocytocine (OT) est un neuropeptide synthétisé au sein de l’hypothalamus. On sait aujourd’hui que l’OT est fortement impliquée dans la modulation de nombreux comportements et émotions. Pourtant, il reste encore difficile d’expliquer comment s’organise le système ocytocinergique, par exemple en sous-ensembles spécifiques. De même, les circuits neuronaux impliqués dans leur recrutement restent obscures, tout comme leur potentielle plasticité. C’est pourquoi, au cours de ma thèse, je me suis attachée à mieux comprendre ces différents points. Les résultats obtenus ont montré que i) un sous-ensemble spécifique de neurones OT est recruté par la peur ; ii) le système OT fait preuve d’une grande plasticité après une exposition à un contexte effrayant ; iii) le neuropeptide S est capable de recruter une sous-population de neurones OT afin d’exercer une action anxiolytique ; iv) les neurotransmetteurs monoaminergiques sont eux-mêmes capables de recruter différents sous-ensembles de neurones OT. En conclusion, mon travail a mis en évidence la plasticité de ce système peptidergique et différentes manières de recruter de manière spécifiques certains sous-ensembles existants de neurones OT. / Oxytocin (OT) is a peptide synthesized within the hypothalamus. We now know that OT is strongly involved in the modulation of many behaviors and emotions. However, it is still difficult to explain how the oxytocinergic system is organized, for example in specific sub-populations. Similarly, the neuronal circuits involved in their recruitment remain obscure, like their potential plasticity. That is why, during my thesis, I tried to better understand these different points. The results obtained showed that i) a specific sub-population of OT neurons is recruited by fear; ii) the OT system exhibits great plasticity after exposure to a scary context; iii) the neuropeptide S is able to recruit an OT neuron sub-population in order to exert an anxiolytic effect; iv) monoaminergic neurotransmitters are themselves able to recruit different sub-populations of OT neurons. In conclusion, my work has highlighted the plasticity of this peptidergic system and different ways to recruit in a specific manner some existing sub-populations of OT neurons.

<p>Neuropeptide Y (NPY) is known to influence a vast number of physiological and behavioral processes such as vasoconstriction, circadian rhythms, feeding, anxiety and memory. Peptides of the NPY family bind to five different cloned G-protein coupled receptor subtypes (Y1, 2, 4-6). The studies compiled in this thesis present inter-species comparisons of sequence similarities, binding properties and expression patterns among receptors of the NPY family.</p><p>Cloning of Y1 and Y2 receptor subtypes from guinea pigs revealed strong binding profile similarity to the corresponding human receptors. Previously demonstrated atypical binding profiles in the caval vein of guinea pigs were concluded to result from other receptors than the cloned Y1 and Y2 receptors, or possibly combinations of distinct receptor subtypes.</p><p>The guinea pig Y5 receptor was found to be expressed in regions of the brain that have been indicated as important for regulation of food intake. Expression in the hypothalamus, amygdala and brain stem was noticed, similar to studies in rats and humans. In other brain regions, such as the striatum and hippocampus, some species differences were observed.</p><p>Mutagenesis studies of the human Y1 receptor indicated sites important for binding both of endogenous agonists and synthetic antagonists. Putative new sites of interaction with the Y1 antagonists BIBP3226 and/or SR120819A were recognized. The data were used to construct a three-dimensional structure model, based on a high-resolution bovine rhodopsin model.</p><p>Cloning of the chicken (<i>Gallus gallus</i>) Y1, Y2 and Y5 receptors revealed high sequence similarities with mammalian receptors. Most endogenous ligands bound with similar affinities as to mammalian receptors. The strongest exception was the discovery of high-affinity binding to chicken Y2 of [Leu³¹, Pro³⁴]NPY, which was previously considered to bind non-Y2 receptors only. </p><p>The new human Y1 receptor model provides a basis for further investigations of ligand-receptor interactions which will be aided by information on NPY receptors from other taxa. Guinea pigs are concluded to be a good complement to rats and mice for studying NPY signaling. These results demonstrate the benefits of species comparisons for pharmacological studies.</p>

Neuropeptide Y (NPY) is known to influence a vast number of physiological and behavioral processes such as vasoconstriction, circadian rhythms, feeding, anxiety and memory. Peptides of the NPY family bind to five different cloned G-protein coupled receptor subtypes (Y1, 2, 4-6). The studies compiled in this thesis present inter-species comparisons of sequence similarities, binding properties and expression patterns among receptors of the NPY family. Cloning of Y1 and Y2 receptor subtypes from guinea pigs revealed strong binding profile similarity to the corresponding human receptors. Previously demonstrated atypical binding profiles in the caval vein of guinea pigs were concluded to result from other receptors than the cloned Y1 and Y2 receptors, or possibly combinations of distinct receptor subtypes. The guinea pig Y5 receptor was found to be expressed in regions of the brain that have been indicated as important for regulation of food intake. Expression in the hypothalamus, amygdala and brain stem was noticed, similar to studies in rats and humans. In other brain regions, such as the striatum and hippocampus, some species differences were observed. Mutagenesis studies of the human Y1 receptor indicated sites important for binding both of endogenous agonists and synthetic antagonists. Putative new sites of interaction with the Y1 antagonists BIBP3226 and/or SR120819A were recognized. The data were used to construct a three-dimensional structure model, based on a high-resolution bovine rhodopsin model. Cloning of the chicken (Gallus gallus) Y1, Y2 and Y5 receptors revealed high sequence similarities with mammalian receptors. Most endogenous ligands bound with similar affinities as to mammalian receptors. The strongest exception was the discovery of high-affinity binding to chicken Y2 of [Leu31, Pro34]NPY, which was previously considered to bind non-Y2 receptors only. The new human Y1 receptor model provides a basis for further investigations of ligand-receptor interactions which will be aided by information on NPY receptors from other taxa. Guinea pigs are concluded to be a good complement to rats and mice for studying NPY signaling. These results demonstrate the benefits of species comparisons for pharmacological studies.

Le traitement des douleurs sévères repose dans la plupart des cas sur l’utilisation d’analgésiques opiacés. Cependant après administration répétée d’analgésique morphinique, on observe une tolérance aux agents morphiniques. Au niveau moléculaire, l’hypothèse physiopathologique met en avant la participation de systèmes ‘’dits anti-opiacés’’, comme le système du neuropeptide FF (NPFF). Dans un premier temps, une méthode de synthèse a été développée pour introduire divers α-aminoacides sur les chlorures d’α-hétéroaryle correspondants. Cette méthode originale, faisant appel aux conditions et catalyseurs décrits par Buchwald, a conduit à la découverte de ligands puissants de ces récepteurs. D’autre part, notre travail s’est basé sur la conception, la synthèse et l’étude des relations structure-activité d’autres familles de ligands pour les récepteurs du NPFF. Plusieurs séries de molécules ont été étudiées, parmi elles deux grandes familles : les aminoguanidines hydrazones et les quinolin-2-yl guanidines. Cette étude nous a permis d’identifier plusieurs ligands actifs in vitro (nanomolaire) et in vivo sur les récepteurs du NPFF. Ainsi nous disposons actuellement de ligands sélectifs vis-à-vis des deux récepteurs du NPFF. Une difficulté de synthèse des aryl/hétéroaryl guanidines a été rencontrée, en particulier avec les anilines appauvries en électrons. Pour cela nous avons développé une méthode de guanidinylation directe des halogénures d’aryle/hétéroaryle catalysée par le cuivre. Cette méthode de synthèse de dérivés de guanidines N-monosubstituées s’est montré très efficace, généralisable à quasiment tous les systèmes aromatiques et hétéroaromatiques. Enfin, quelques observations inattendues au cours de la réalisation de la réaction de Buchwald ont été décrites. / The treatment of severe pain involves in most cases the use of opioid analgesics such as morphine or fentanyl. However, after repeated administration of narcotic analgesics, a tolerance to opioid agents is observed. This result needs to gradually increase the dose of drug to obtain the desired analgesic effect. At the molecular level, the pathophysiological hypothesis emphasizes the participation of so-called ''anti-opioid'' systems, like the neuropeptide FF (NPFF) system. Initially, a synthetic method was developed to introduce various α-amino acids on various α-heteroaryl chlorides. This original method, using the conditions and catalysts described by Buchwald, led to potent NPFF receptor ligands. Then, our work was based on the design, synthesis and study of structure-activity relationships of other ligands for NPFF receptors. Several series of molecules have been studied. Among them two large families were selected: aminoguanidine hydrazones and quinolin-2-yl guanidines. This study allowed us to identify several potent ligands in vitro (nanomolar Ki) and active in vivo. So we have now selective ligands towards the two NPFF receptors. A loss of reactivity during the synthesis of aryl / heteroaryl guanidines was observed, in particular with electron deficient anilines. For these compounds we developed a new method of direct guanidinylation of aryl and heteroaryl halides catalyzed by copper. This method of synthesis of N-monosubstituted guanidines is very effective, generalizable to almost all aromatic and heteroaromatic systems. Finally, some unexpected observations during the completion of Buchwald reaction were described.

Investigou-se o efeito da leptina exógena e do maior consumo de energia, sobre o padrão da expressão de genes no hipotálamo de novilhas zebuínas; de modo a elucidar o mecanismo de sinalização da leptina no hipotálamo e os genes responsáveis pela obtenção da puberdade. Trinta e seis novilhas não púberes, e com idade entre 18 e 20 meses, foram divididas em três grupos experimentais: baixa energia (BAIXA), alta energia (ALTA), baixa energia com administração de leptina recombinante ovina (BAIXA+LEP), totalizando 56 dias de tratamento. Vinte e quatro novilhas foram abatidas ao apresentar sinais de puberdade, sendo eles: concentração de progesterona no soro superior a 1 ng/mL por duas amostras seguidas e presença de corpo lúteo detectável por ultra-sonografia. O hipotálamo foi colhido e armazenado a -80ºC. As amostras foram submetidas à extração do RNA total, tratadas com DNAse I e submetidas à síntese de cDNA. A quantificação relativa de quatro genes candidatos reconhecidamente envolvidos com a sinalização hipotalâmica da leptina em bovinos: NPY, NPY-Y1, NPY-Y4 e SOCS-3, foi feita através de PCR quantitativo (tempo real). Não houve efeito da administração de leptina sobre a expressão do NPY (P=0,70), ou de seus receptores: NPY-Y1 (P=0,27) e NPY-Y4 (P=0,92) no início da puberdade. A expressão de SOCS-3 foi reduzida (P=0,05) no hipotálamo de novilhas tratadas com leptina, o que sugere menor ação inibitória sobre a leptina. Em novilhas alimentadas com dieta de alta energia, a expressão do NPY-Y1 foi reduzida (P=0,04), o que indica que o hipotálamo estaria menos sensível à ação do NPY, permitindo a entrada precoce em puberdade. Nos demais genes estudados, NPY (P=0,75), NPY-Y4 (P=0,92) e SOCS-3 (P=0,24), a dieta não alterou significativamente suas expressões hipotalâmicas. Estudo mais abrangente do efeito da nutrição e da administração de leptina foi realizado através de hibridização em microarranjos de DNA, objetivando a identificação de possíveis genes candidatos, expressos no hipotálamo, que influenciam na obtenção da puberdade em novilhas Nelore tratadas com leptina ou submetidas à dieta de alta energia. Foram encontrados 78 genes cuja expressão foi alterada pela densidade energética da dieta (P=0,05) no hipotálamo das novilhas Nelore, destes foram selecionados os que apresentaram razões de expressão da ordem de 1,4 ou mais, totalizando 20 genes. Entre esses se destaca o gene da &beta;-arrestina 1 (ARRB1), que foi 1,40 vezes mais expresso (P=0,04) em novilhas submetidas à dieta de alta energia, pois atua na mediação da dessensibilização dos receptores acoplados à proteína-G-(GPCRs)1, como os receptores de NPY. Foram encontrados 134 genes diferencialmente expressos (P=0,05) devido a aplicação de leptina. Dentre os 80 genes que apresentaram razões superiores a 1,4, 18 genes tiveram a expressão reduzida, e 62 tiveram a expressão aumentada pela aplicação de leptina. Destes, alguns estão envolvidos na regulação da sinalização da leptina. O gene SRC foi menos expresso (1,64 vezes; P=0,04) em novilhas tratadas com leptina, o que sugere menor ação inibitória pela SHP-2. A proteína SOCS-2 foi 1,43 vezes (P=0,01) mais expressa no hipotálamo de novilhas tratadas com leptina. Sabe-se que, ao contrário de SOCS-1 e SOCS-3, CIS e SOCS-2 não se ligam, ou inibem, as janus kinases. O STAT-3 foi 2,14 vezes (P=0,03) mais expresso em novilhas tratadas com leptina, e sua ativação possibilita a ligação hipotalâmica da leptina com seu receptor (Ob-Rb). As IGFPB-1 e -2 foram mais expressas no hipotálamo de novilhas tratadas com leptina que em novilhas não tratadas, sendo IGFPB-1 1,78 vezes (P=0,04) mais expressa e IGFPB-2 1,89 vezes (P=0,05). As IGFPBs podem desempenhar função de potencialização da ação do IGF-1, ou exercer ação inibitória. Conclui-se que tanto o consumo de energia quanto a aplicação com leptina influenciaram o padrão de expressão gênica no hipotálamo de novilhas Nelore. A modulação da quantidade do receptor do NPY, NPY-Y1, no hipotálamo pode ser uma via importante pela qual a nutrição afeta o início da puberdade em novilhas. E ainda que estudos mais aprofundados de expressão dos genes encontrados nas hibridizações por microarranjo poderão revelar interações mais concisas entre os genes, a nutrição e a leptina na obtenção da puberdade. / It was investigated the effect of exogenous leptin and the high energy intake on gene expression pattern in the hypothalamus of zebuine heifers; in a way to elucidate the mechanism of leptin signaling in hypothalamus and the responsible genes for puberty. Thirty six heifers not in puberty at 18 and 20 months of age were divided in three experimental groups: low energy diet (LOW), high energy diet (HIGH), low energy diet with administration of recombinant ovine leptin (LOW+LEP), totalizing 56 days of treatment. Twenty four heifers were slaughtered when presented the signals of puberty: progesterone serum concentration above 1 ng/mL for two followed weeks and the presence of detectable corpus luteum by ultrasonography. The hypothalamus was collected and stored at -80ºC. Samples were submitted to total RNA extraction, treated with DNAse I and submitted to cDNA synthesis. The relative quantification of four candidate genes admittedly involved with hypothalamic leptin signaling in bovine: NPY, NPY-Y1, NPY-Y4 and SOCS-3, was evaluated through quantitative PCR (real time). There was no effect of leptin administration on NPY expression (P=0.70), or on its receptors: NPY-Y1 (P=0.27) and NPY-Y4 (P=0.92) in the onset of puberty. The expression of SOCS-3 was reduced (P=0.05) in the hypothalamus of heifers treated with leptin, what suggests lower inhibitory action over leptin. In heifers fed high energy diets, the expression of NPY-Y1 was reduced (P=0.04), which indicates that the hypothalamus would be less sensitive to the action of NPY, allowing the precocious onset of puberty. In other studied genes, NPY (P=0.75), NPY-Y4 (P=0.92) and SOCS-3 (P=0.24), the diet did not significantly altered their hypothalamic expressions. A more comprehensive study regarding the effect of nutrition and leptin administration was performed through the hybridization in DNA microarrangements, aiming the identification of possible candidate genes, expressed in hypothalamus that influence in the onset of puberty in Nelore heifers treated with leptin or submitted to high energy diets. It was found 78 genes whose expression was altered by the energy density of the diet (P<0.05) in the hypothalamus of Nelore heifers. From them, it was selected those genes which presented rates of expression in the order of 1.4 or more, totalizing 20 genes. From them, the highlight gene was &beta;-arrestin 1 (ARRB1) which was 1.40 more expressed (P=0.04) in heifers fed high energy diet due to its action in the mediation of receptors desensibilization coupled to protein-G-(GPCRs)1, as the receptors of NPY. It was found 134 genes differently expressed (P<0.05) due to leptin administration. From the 80 genes that presented rates of expression higher than 1.4, 18 genes had their expression reduced and 62 had their expression increased by leptin administration. Some of these 62 genes are involved in the regulation of leptin signaling. The gene SRC was the less expressed (1.64 times; P=0.04) in heifers treated with leptin what suggests lower inhibitory action by SHP-2. The protein SOCS-2 was 1.43 times (P=0.01) more expressed in the hypothalamus of heifers treated with leptin. It is known that on the contrary of SOCS-1 and SOCS-3, CIS and SOCS-2 do not bind or inhibit, as janus kinases. The STAT-3 was 2.14 times (P=0.03) more expressed in heifers treated with leptin and its activation enables the hypothalamic binding of leptin and its receptor (Ob-Rb). The IGFPB-1 and -2 were more expressed in the hypothalamus of heifers treated with leptin than the animals not treated, being the IGFPB-1 1.78 times (P=0.04) more expressed and the IGFPB-2 1.89 times (P=0.05). The IGFPBs could play a function of IGF-1 action enhancer or exert an inhibitory action. It is concluded that both energy intake and leptin administration influenced gene expression pattern in the hypothalamus of Nelore heifers. The modulation of the receptor quantity of NPY, NPY-Y1 in hypothalamus could be an important route in which nutrition affects the onset of puberty in heifers. Moreover, more detailed studies regarding gene expression in hybridization by microarrangement could reveal more concise interactions between genes, nutrition and leptin in the onset of puberty.